
|Articles|August 20, 2014
The Medical Innovation Threat
Advertisement
An invasive species has been introduced into the U.S. health innovation ecosystem, with a growing danger of permanent damage to the development of specialty drugs. The relentless assault on the price of Sovaldi is becoming a threat to the 30-year political balance that has energized the biomedical revolution.
Source: The Wall Street Journal
Read the full story:
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Related Content
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves First-in-Class Optune Pax Device for Pancreatic Cancer
2
Bipartisan Break Up Big Medicine Act Targets Vertical Integration in Health Care
3
3-Year EPCORE NHL-1 Data Published Showing 53% Have Deep, Durable Remission
4
Sun-Smart Habits, Self-Screening Reduce Skin Cancer Risk: Vishal A. Patel, MD
5
















